# Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP

> **NCT05996588** · PHASE4 · COMPLETED · sponsor: **Sindh Institute of Urology and Transplantation** · enrollment: 86 (actual)

## Conditions studied

- Sedation Complication

## Interventions

- **DRUG:** Propofol 1 % Injectable Suspension
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT05996588
- **Lead sponsor:** Sindh Institute of Urology and Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-05
- **Primary completion:** 2022-11-25
- **Final completion:** 2022-11-25
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05996588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05996588, "Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05996588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*